$8.98
+0.11
(+1.24%)▲
Insights on Alx Oncology Holdings Inc
In the last 1 year, Seagen, Inc. has given 76.9% return, outperforming this stock by 88.8%
In the last 3 years, Novo Nordisk A/s has given 26.8% return, outperforming this stock by 113.9%
4.12%
Downside
Day's Volatility :6.21%
Upside
2.18%
56.12%
Downside
52 Weeks Volatility :68.05%
Upside
27.17%
Period | Alx Oncology Holdings Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 111.69% | -2.6% | 0.0% |
6 Months | 32.78% | 2.2% | 0.0% |
1 Year | -11.92% | -4.3% | -3.4% |
3 Years | -88.47% | 19.1% | -4.7% |
Market Capitalization | 488.2M |
Book Value | $4.1 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -3.57 |
Wall Street Target Price | 15.25 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -35.9% |
Return On Equity TTM | -64.09% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | -100.0% |
Gross Profit TTM | 107.0K |
EBITDA | -153.7M |
Diluted Eps TTM | -3.57 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -3.61 |
EPS Estimate Next Year | -3.3 |
EPS Estimate Current Quarter | -0.87 |
EPS Estimate Next Quarter | -0.79 |
What analysts predicted
Upside of 69.82%
Sell
Neutral
Buy
Alx Oncology Holdings Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Alx Oncology Holdings Inc | 28.92% | 32.78% | -11.92% | -88.47% | -70.43% |
![]() Moderna, Inc. | 4.93% | -38.23% | -55.68% | -49.12% | 317.85% |
![]() Regeneron Pharmaceuticals, Inc. | 2.62% | 9.54% | 7.63% | 54.66% | 119.47% |
![]() Novo Nordisk A/s | 7.75% | 29.99% | 71.36% | 209.46% | 351.9% |
![]() Seagen, Inc. | 0.13% | 10.52% | 76.89% | 25.9% | 249.5% |
![]() Vertex Pharmaceuticals Incorporated | -2.03% | 7.65% | 11.07% | 53.76% | 96.32% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Alx Oncology Holdings Inc | NA | NA | NA | -3.61 | -0.64 | -0.36 | 0.0 | 4.1 |
![]() Moderna, Inc. | 24.73 | NA | 0.0 | -12.11 | -0.22 | -0.07 | 0.0 | 35.32 |
![]() Regeneron Pharmaceuticals, Inc. | 22.78 | 22.78 | 9.01 | 42.51 | 0.17 | 0.09 | 0.01 | 234.47 |
![]() Novo Nordisk A/s | 41.76 | 41.76 | 2.03 | 2.65 | 0.89 | 0.22 | 0.01 | 20.77 |
![]() Seagen, Inc. | NA | NA | 18.53 | -4.16 | -0.28 | -0.13 | 0.03 | 13.52 |
![]() Vertex Pharmaceuticals Incorporated | 26.68 | 26.68 | 0.41 | 15.04 | 0.23 | 0.14 | 0.02 | 64.05 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Alx Oncology Holdings Inc | Buy | $488.2M | -70.43% | NA | 0.0% |
![]() Moderna, Inc. | Buy | $29.8B | 317.85% | 24.73 | -38.0% |
![]() Regeneron Pharmaceuticals, Inc. | Buy | $87.0B | 119.47% | 22.78 | 30.47% |
![]() Novo Nordisk A/s | Buy | $458.4B | 351.9% | 41.76 | 35.11% |
![]() Seagen, Inc. | Hold | $40.0B | 249.5% | NA | -32.61% |
![]() Vertex Pharmaceuticals Incorporated | Buy | $91.4B | 96.32% | 26.68 | 35.94% |
venBio Partners LLC
FMR Inc
Vivo Capital, LLC
Orbimed Advisors, LLC
BlackRock Inc
Redmile Group, LLC
Alx Oncology Holdings Inc’s price-to-earnings ratio stands at None
Read Morealx oncology (previously alexo therapeutics) is a clinical-stage immuno-oncology company developing therapies that block the cd47 myeloid checkpoint mechanism exploited by cancer cells to evade the immune system. our lead candidate, alx148, is a fusion protein that comprises an engineered high affinity cd47 binding domain of sirpa linked to an inactive fc region of human immunoglobulin. alx148 is currently being investigated in a phase 1 study in combination with checkpoint inhibitors and targeted anti-cancer antibodies (nct03013218). for more information about the company, please visit our website at www.alxoncology.com
Organization | Alx Oncology Holdings Inc |
Employees | 71 |
CEO | Dr. Corey S. Goodman Ph.D. |
Industry | Commercial Services |
Asymmetric Smart Alpha S&p 500 Etf
$8.98
+1.24%
Advisorshares Alpha Dna Equity Sentiment Etf
$8.98
+1.24%
Liberty Tripadvisor Hdg-b
$8.98
+1.24%
Tempo Automation Holdings Inc
$8.98
+1.24%
Falcon's Beyond Global Inc
$8.98
+1.24%
Jaguar Global Growth Corporation I
$8.98
+1.24%
Missfresh Ltd
$8.98
+1.24%
Shuaa Partners Acquisition Corp I
$8.98
+1.24%
Rose Hill Acquisition Corp
$8.98
+1.24%